- Home
- MGRX
MGRX
Mangoceuticals Inc.
as 07-26-2024 4:00pm EST
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Upcoming Earnings Alert:
Get ready for potential market movements as Mangoceuticals Inc. MGRX prepares to release earnings report on 30 Jul 2024.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 9.3M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.14 - $1.59 | Next Earning Date: | 07-30-2024 |
| Revenue: | $844,866 | Revenue Growth: | 670.43% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Mangoceuticals Inc. (MGRX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | MGRX | Director | Jun 25 '24 | Sell | $0.31 | 16,574 | $5,137.94 | 158,426 | SEC Form 4 |
| Hamilton Alex P. | MGRX | Director | Jun 25 '24 | Sell | $0.32 | 108,426 | $34,696.32 | 50,000 | SEC Form 4 |
Latest Mangoceuticals Inc. News
MGRX Breaking Stock News: Dive into MGRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
GlobeNewswire
8 days ago
Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access
GlobeNewswire
11 days ago
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
GlobeNewswire
14 days ago
MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department
GlobeNewswire
16 days ago
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
AFP
2 months ago
Seoul says it will resume loudspeaker propaganda against North
Compare MGRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGRX Mangoceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.